Forte Biosciences Inc. buy stratec
Start price
19.12.18
/
50%
€113.92
Target price
20.12.18
€323.37
Performance (%)
-5.05%
End price
20.12.18
€108.17
Summary
This prediction ended on 20.12.18 with a price of €108.17. With a performance of -5.05%, the BUY prediction by stratec finished with a loss. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Forte Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | -0,44 % | -5,31 % | 1,44 % | 57,85 % |
| iShares Nasdaq 100 | -0,19 % | 3,08 % | 18,68 % | 84,82 % |
| iShares Nikkei 225® | -0,95 % | -5,88 % | 27,86 % | 54,81 % |
| iShares S&P 500 | -0,42 % | 0,92 % | 13,17 % | 64,03 % |
Comments by stratec for this prediction
In the thread Tocagen diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 19.12.2018 der Buy-Einschätzung von tamam mit dem Kursziel 23,9$ zu.
Überschrift: Tocagen: Highly Promising And Deeply Undervalued Biotech
(Stop Loss Kurs erreicht)